CATX
Perspective Therapeutics, Inc.$2.74-0.18 (-6.34%)Prev Close$2.92·MCap$320.5M·P/E—·Vol1.08M·Yield—
▲
Buys (12M)
2
$42.2K
▼
Sells (12M)
4
$1.62M
◆
Net Activity
Net Seller
$1.58M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Perspective Therapeutics, Inc. (CATX) has been dominated by selling, with 2 insider purchases totaling $42.2K and 4 insider sales totaling $1.62M. The most recent insider transaction was by Lantheus Alpha Therapy, LLC (10 percent owner), who sold $776.9K worth of shares on Sep 8, 2026. Perspective Therapeutics, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $320.5M.
CATX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Lantheus Alpha Therapy, LLC | 10 percent owner | Sell | 247,932 | $3.13 | $776.9K | 11,440,513 |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC | 10 percent owner | Sell | 156,043 | $3.13 | $488.4K | 11,599,194 |
| Sep 3, 2026 | Lantheus Holdings, Inc. | 10 percent owner | Sell | 35,769 | $3.12 | $111.6K | 11,563,425 |
| Sep 2, 2026 | Lantheus Holdings, Inc. | 10 percent owner | Sell | 78,145 | $3.14 | $245.6K | 11,599,194 |
| Nov 13, 2025 | Hunt Jonathan Robert | Chief Accounting Officer | Buy | 11,000 | $2.03 | $22.3K | 0 |
| Nov 12, 2025 | Williamson Robert F III | Director | Buy | 9,498 | $2.10 | $19.9K | 0 |
| Mar 31, 2025 | Woods Lori A | Director | Buy | 23,475 | $2.13 | $50.0K | 0 |
| Mar 28, 2025 | Graham Juan | Chief Financial Officer | Buy | 33,333 | $2.25 | $74.9K | 0 |
| Mar 28, 2025 | Spoor Johan M. | Chief Executive Officer | Buy | 26,676 | $2.24 | $59.7K | 0 |
| Mar 28, 2025 | Williamson Robert F III | Director | Buy | 60,337 | $2.19 | $132.2K | 0 |
| Dec 4, 2024 | HENSON HEIDI | Director | Buy | 25,975 | $3.85 | $100.0K | 0 |
| Dec 4, 2024 | Spoor Johan M. | CEO | Buy | 8,000 | $3.77 | $30.1K | 0 |
| Nov 25, 2024 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 12,829 | $3.82 | $49.0K | 0 |
| Nov 25, 2024 | Spoor Johan M. | CEO | Buy | 26,500 | $3.79 | $100.5K | 0 |
| Nov 25, 2024 | Williamson Robert F III | Director | Buy | 6,266 | $3.64 | $22.8K | 0 |
| Jun 17, 2024 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 1,800 | $9.82 | $17.7K | 0 |
| Jun 14, 2024 | Woods Lori A | Director | Buy | 4,587 | $10.90 | $50.0K | 0 |
| Jun 13, 2024 | Spoor Johan M. | CEO | Buy | 100,000 | $1.17 | $117.4K | 0 |
| Jun 3, 2024 | Woods Lori A | Director | Buy | 34,246 | $1.46 | $50.0K | 0 |
| May 31, 2024 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 25,006 | $1.40 | $35.0K | 0 |
| May 31, 2024 | Williamson Robert F III | Director | Buy | 55,000 | $1.38 | $75.9K | 0 |
| May 29, 2024 | Williamson Robert F III | Director | Buy | 30,031 | $1.33 | $40.0K | 0 |
| Jan 30, 2024 | Williamson Robert F III | Director | Buy | 127,206 | $0.71 | $90.7K | 0 |
| Jan 26, 2024 | Williamson Robert F III | Director | Buy | 135,879 | $0.58 | $78.5K | 0 |
| Jan 24, 2024 | Puhlmann Markus | Chief Medical Officer | Buy | 280,000 | $0.50 | $139.9K | 0 |
| Jan 24, 2024 | Williamson Robert F III | Director | Buy | 51,996 | $0.49 | $25.5K | 0 |
| Dec 21, 2023 | Williamson Robert F III | Director | Buy | 3,663 | $0.33 | $1.2K | 0 |
| Dec 18, 2023 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 125,000 | $0.26 | $32.3K | 0 |
| Dec 18, 2023 | Williamson Robert F III | Director | Buy | 23,680 | $0.29 | $7.0K | 0 |
| Dec 15, 2023 | Puhlmann Markus | Chief Medical Officer | Buy | 595,425 | $0.32 | $188.7K0.8% OS | 0 |
| Dec 14, 2023 | Woods Lori A | Director | Buy | 185,200 | $0.27 | $50.0K | 0 |
| Dec 1, 2022 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 85,404 | $0.38 | $32.5K | 0 |
| Nov 15, 2022 | Woods Lori A | CEO | Buy | 100,000 | $0.34 | $33.5K | 0 |
| Jun 8, 2022 | Austin Mark John | VP Finance/Prin Fin&Acct Offic | Buy | 18,800 | $0.29 | $5.4K | 0 |
| Jun 7, 2022 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 39,000 | $0.29 | $11.2K | 0 |
| Jun 7, 2022 | Woods Lori A | CEO | Buy | 75,000 | $0.30 | $22.2K | 0 |
| Mar 12, 2021 | Woods Lori A | CEO | Sell | 24,038 | $0.57 | $13.7K | 0 |
CATX Insider Buying Activity
The following table shows recent insider purchases of Perspective Therapeutics, Inc. (CATX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | Hunt Jonathan Robert | Chief Accounting Officer | Buy | 11,000 | $2.03 | $22.3K | 0 |
| Nov 12, 2025 | Williamson Robert F III | Director | Buy | 9,498 | $2.10 | $19.9K | 0 |
| Mar 31, 2025 | Woods Lori A | Director | Buy | 23,475 | $2.13 | $50.0K | 0 |
| Mar 28, 2025 | Graham Juan | Chief Financial Officer | Buy | 33,333 | $2.25 | $74.9K | 0 |
| Mar 28, 2025 | Spoor Johan M. | Chief Executive Officer | Buy | 26,676 | $2.24 | $59.7K | 0 |
| Mar 28, 2025 | Williamson Robert F III | Director | Buy | 60,337 | $2.19 | $132.2K | 0 |
| Dec 4, 2024 | HENSON HEIDI | Director | Buy | 25,975 | $3.85 | $100.0K | 0 |
| Dec 4, 2024 | Spoor Johan M. | CEO | Buy | 8,000 | $3.77 | $30.1K | 0 |
| Nov 25, 2024 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 12,829 | $3.82 | $49.0K | 0 |
| Nov 25, 2024 | Spoor Johan M. | CEO | Buy | 26,500 | $3.79 | $100.5K | 0 |
| Nov 25, 2024 | Williamson Robert F III | Director | Buy | 6,266 | $3.64 | $22.8K | 0 |
| Jun 17, 2024 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 1,800 | $9.82 | $17.7K | 0 |
| Jun 14, 2024 | Woods Lori A | Director | Buy | 4,587 | $10.90 | $50.0K | 0 |
| Jun 13, 2024 | Spoor Johan M. | CEO | Buy | 100,000 | $1.17 | $117.4K | 0 |
| Jun 3, 2024 | Woods Lori A | Director | Buy | 34,246 | $1.46 | $50.0K | 0 |
| May 31, 2024 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 25,006 | $1.40 | $35.0K | 0 |
| May 31, 2024 | Williamson Robert F III | Director | Buy | 55,000 | $1.38 | $75.9K | 0 |
| May 29, 2024 | Williamson Robert F III | Director | Buy | 30,031 | $1.33 | $40.0K | 0 |
| Jan 30, 2024 | Williamson Robert F III | Director | Buy | 127,206 | $0.71 | $90.7K | 0 |
| Jan 26, 2024 | Williamson Robert F III | Director | Buy | 135,879 | $0.58 | $78.5K | 0 |
| Jan 24, 2024 | Puhlmann Markus | Chief Medical Officer | Buy | 280,000 | $0.50 | $139.9K | 0 |
| Jan 24, 2024 | Williamson Robert F III | Director | Buy | 51,996 | $0.49 | $25.5K | 0 |
| Dec 21, 2023 | Williamson Robert F III | Director | Buy | 3,663 | $0.33 | $1.2K | 0 |
| Dec 18, 2023 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 125,000 | $0.26 | $32.3K | 0 |
| Dec 18, 2023 | Williamson Robert F III | Director | Buy | 23,680 | $0.29 | $7.0K | 0 |
| Dec 15, 2023 | Puhlmann Markus | Chief Medical Officer | Buy | 595,425 | $0.32 | $188.7K0.8% OS | 0 |
| Dec 14, 2023 | Woods Lori A | Director | Buy | 185,200 | $0.27 | $50.0K | 0 |
| Dec 1, 2022 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 85,404 | $0.38 | $32.5K | 0 |
| Nov 15, 2022 | Woods Lori A | CEO | Buy | 100,000 | $0.34 | $33.5K | 0 |
| Jun 8, 2022 | Austin Mark John | VP Finance/Prin Fin&Acct Offic | Buy | 18,800 | $0.29 | $5.4K | 0 |
| Jun 7, 2022 | Hunt Jonathan Robert | Chief Financial Officer | Buy | 39,000 | $0.29 | $11.2K | 0 |
| Jun 7, 2022 | Woods Lori A | CEO | Buy | 75,000 | $0.30 | $22.2K | 0 |
CATX Insider Selling Activity
The following table shows recent insider sales of Perspective Therapeutics, Inc. (CATX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Lantheus Alpha Therapy, LLC | 10 percent owner | Sell | 247,932 | $3.13 | $776.9K | 11,440,513 |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC | 10 percent owner | Sell | 156,043 | $3.13 | $488.4K | 11,599,194 |
| Sep 3, 2026 | Lantheus Holdings, Inc. | 10 percent owner | Sell | 35,769 | $3.12 | $111.6K | 11,563,425 |
| Sep 2, 2026 | Lantheus Holdings, Inc. | 10 percent owner | Sell | 78,145 | $3.14 | $245.6K | 11,599,194 |
| Mar 12, 2021 | Woods Lori A | CEO | Sell | 24,038 | $0.57 | $13.7K | 0 |
CATX Insiders
Similar Stocks to CATX
SYK
Stryker Corporation
$281.11-0.32%
$105.57B
BSX
Boston Scientific Corporation
$43.93-2.48%
$66.83B
EW
Edwards Lifesciences Corporation
$85.82+0.33%
$49.62B
DXCM
DexCom, Inc.
$86.69+2.37%
$31.33B
ZBH
Zimmer Biomet Holdings, Inc.
$99.10+2.61%
$18.09B
GMED
Globus Medical, Inc.
$74.78-1.29%
$10.01B
GKOS
Glaukos Corporation
$172.13+0.61%
$9.87B
PODD
Insulet Corp.
$139.63+1.32%
$9.14B